Immune homeostasis requires several biologic factors including glucocorticoid hormones

被引:15
作者
Cancedda, C [1 ]
Filaci, G [1 ]
Puppo, F [1 ]
Ghio, M [1 ]
Contini, P [1 ]
Indiveri, F [1 ]
机构
[1] Univ Genoa, Dept Internal Med, Div Clin Immunol, I-16132 Genoa, Italy
来源
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS | 2002年 / 966卷
关键词
immunological activity; T cells; corticosteroids; soluble Fas ligand; hormones;
D O I
10.1111/j.1749-6632.2002.tb04201.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immunological tolerance can be achieved by several mechanisms including suppressor cells, soluble factors, and neurohormonal mediators. On the cellular level, we isolated a population of CD8+CD28- T cells capable of inhibiting anti-CD3 mAb-induced proliferation of autologous peripheral blood mononuclear cells in an HLA-I nonrestricted manner via production of IFN-gamma and IL-6. Interestingly, CD8+CD28- T cells from systemic lupus erythematosus patients with active disease do not display this inhibitory activity and show a marked imbalance between inhibitory (IL-6) and stimulatory (IL-12) cytokines. For soluble factors, we studied soluble HLA molecules (sHLAs) and double-stranded DNA (ds-DNA). Soluble HLA-I (sHLA-I) molecules induce soluble Fas ligand (sFasL) secretion and trigger apoptosis in phytohemagglutin (PHA)-activated Fas+ T cells. Double-stranded DNA binds to HLA-II molecules and inhibits HLA-II-mediated antigen presentation. On the neurohormonal side, we focused our attention on the immunological activity of corticosteroids (CTSs). CTSs inhibit recirculation of CD4+ T cells, suppress the proliferation and immunological function of activated T cells, and induce apoptosis of activated lymphocytes. Taken together, these data suggest the presence of a complex network of immunoregulatory mechanisms in which CTSs play a strong role supporting their recognized efficacy in the treatment of inflammatory and immunological diseases.
引用
收藏
页码:49 / 63
页数:15
相关论文
共 25 条
  • [1] ALLISON JP, 1977, J IMMUNOL, V118, P1004
  • [2] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS
    AUPHAN, N
    DIDONATO, JA
    ROSETTE, C
    HELMBERG, A
    KARIN, M
    [J]. SCIENCE, 1995, 270 (5234) : 286 - 290
  • [3] GLUCOCORTICOSTEROID THERAPY - MECHANISMS OF ACTION AND CLINICAL CONSIDERATIONS
    FAUCI, AS
    DALE, DC
    BALOW, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 1976, 84 (03) : 304 - 315
  • [4] Filaci G, 1998, EUR J IMMUNOL, V28, P3968
  • [5] Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus
    Filaci, G
    Bacilieri, S
    Fravega, M
    Monetti, M
    Contini, P
    Ghio, M
    Setti, M
    Puppo, F
    Indiveri, F
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (10) : 6452 - 6457
  • [6] CIRCULATING DNA AND LUPUS NEPHRITIS
    FOURNIE, GJ
    [J]. KIDNEY INTERNATIONAL, 1988, 33 (02) : 487 - 497
  • [7] Soluble HLA class I and Fas ligand molecules in blood components and their role in the immunomodulatory effects of blood transfusions
    Ghio, M
    Contini, P
    Mazzei, C
    Brenci, S
    Filaci, G
    Indiveri, F
    Puppo, F
    [J]. LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 29 - 36
  • [8] DEFLAZACORT IN THE TREATMENT OF HEMATOLOGIC DISORDERS
    GOBBI, M
    SCUDELETTI, M
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 : S25 - S28
  • [9] CIRCADIAN VARIATIONS OF AUTOLOGOUS MIXED LYMPHOCYTE REACTIONS AND ENDOGENOUS CORTISOL
    INDIVERI, F
    PIERRI, I
    ROGNA, S
    POGGI, A
    MONTALDO, P
    ROMANO, R
    PENDE, A
    MORGANO, A
    BARABINO, A
    FERRONE, S
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 82 (01) : 17 - 24
  • [10] VARIOUS MODES OF GENE-REGULATION BY NUCLEAR RECEPTORS FOR STEROID AND THYROID-HORMONES
    KARIN, M
    YANGYEN, HF
    CHAMBARD, JC
    DENG, T
    SAATCIOGLU, F
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 : S9 - S15